Related Experiment Video
Updated: May 10, 2025
Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
Published on: October 10, 2017
An Overview of the Effects of Lithium on Alzheimer's Disease: A Historical Perspective
Marcia Radanovic1,2, Monique Patricio Singulani1,2,3, Vanessa de Jesus R De Paula1,2
1Laboratory of Neuroscience (LIM-27), Department and Institute of Psychiatry, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo 05403-010, SP, Brazil.
Insights
Lithium is an essential medication for bipolar disorder, effectively managing mania and preventing relapse. Emerging research highlights its neuroprotective benefits, suggesting potential for treating neurodegenerative diseases like Alzheimer's.
Area of Science:
- Psychiatry and Neurology
- Pharmacology
Background:
- Lithium salts are essential medications, widely used since the late 19th century for psychiatric disorders.
- They are the most effective treatment for acute mania and relapse prevention in bipolar disorder.
- Current guidelines incorporate lithium for its mood-stabilizing, suicide-risk-reducing, and neuroprotective properties.
Purpose of the Study:
- To review the historical context and discovery of lithium in psychiatric practice.
- To explore the mechanisms of action of lithium.
- To discuss the potential of lithium in treating and preventing neurodegenerative disorders, with a focus on Alzheimer's disease.
Main Methods:
- Historical review of lithium's introduction and use in psychiatry.
- Examination of scientific literature on lithium's mechanisms of action.
- Analysis of translational research and clinical data regarding lithium's efficacy in neurological conditions.
Main Results:
- Lithium remains a cornerstone treatment for bipolar disorder, offering superior efficacy in mania management and relapse prevention.
- Evidence suggests lithium possesses neuroprotective qualities and may mitigate suicide risk.
- Translational research indicates pleiotropic effects beneficial for brain health and potentially other organ systems.
Conclusions:
- Lithium's established efficacy in psychiatric care, coupled with its neuroprotective potential, warrants further investigation for neurodegenerative diseases.
- Its broad therapeutic benefits support its consideration as an essential medication beyond mood stabilization.
- Future research should focus on elucidating lithium's role in preventing and treating conditions like Alzheimer's disease.
Abstract:
Lithium was introduced into psychiatric practice in the late nineteenth century and has since become a standard treatment for severe psychiatric disorders, particularly those characterized by psychotic agitation. It remains the most effective agent for managing acute mania and preventing relapses in bipolar disorder. Despite potential adverse effects, lithium's use should be carefully considered relative to other treatment options, as these alternatives may present distinct safety and tolerability profiles. The World Health Organization classifies lithium salts as 'essential' medications for inclusion in global healthcare systems. Over the past two decades, the growing recognition of lithium's efficacy-extending beyond mood stabilization to include reducing suicide risk and inducing neuroprotection-has led to its incorporation into clinical practice guidelines. Current research, particularly from translational models, suggests that lithium's pleiotropic effects benefit not only mental and brain health but also other organs and systems. This supports its potential as a therapeutic candidate for neurological conditions, particularly those associated with neurodegenerative processes. This article will discuss the historical background, discovery, and early experimentation of lithium in psychiatry. We will also review its mechanisms of action and discuss its potential in the treatment and prevention of neurodegenerative disorders, focusing on Alzheimer's disease.
More Related Videos
09:45Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
07:57An Alternative Approach to Study Primary Events in Neurodegeneration Using Ex Vivo Rat Brain Slices
Published on: April 11, 2018
Related Concept Videos
01:26Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
01:22Alzheimer's Disease: Treatment
01:24Mania and Antimanic Drugs: Overview
01:03Long-term Depression
Calcium Ion Concentration Mechanism
If over...
01:25Long-term Potentiation
Hebbian LTP
LTP can occur when...
01:23Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...